BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 27176797)

  • 1. All-trans retinoic acid and interferon-α increase CD38 expression on adult T-cell leukemia cells and sensitize them to T cells bearing anti-CD38 chimeric antigen receptors.
    Mihara K; Yoshida T; Ishida S; Takei Y; Kitanaka A; Shimoda K; Morishita K; Takihara Y; Ichinohe T
    Blood Cancer J; 2016 May; 6(5):e421. PubMed ID: 27176797
    [No Abstract]   [Full Text] [Related]  

  • 2. Pre-clinical evaluation of CD38 chimeric antigen receptor engineered T cells for the treatment of multiple myeloma.
    Drent E; Groen RW; Noort WA; Themeli M; Lammerts van Bueren JJ; Parren PW; Kuball J; Sebestyen Z; Yuan H; de Bruijn J; van de Donk NW; Martens AC; Lokhorst HM; Mutis T
    Haematologica; 2016 May; 101(5):616-25. PubMed ID: 26858358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T cells bearing anti-CD19 and/or anti-CD38 chimeric antigen receptors effectively abrogate primary double-hit lymphoma cells.
    Mihara K; Yoshida T; Takei Y; Sasaki N; Takihara Y; Kuroda J; Ichinohe T
    J Hematol Oncol; 2017 Jun; 10(1):116. PubMed ID: 28595585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retinoic acid-induced expression of CD38 antigen in myeloid cells is mediated through retinoic acid receptor-alpha.
    Drach J; McQueen T; Engel H; Andreeff M; Robertson KA; Collins SJ; Malavasi F; Mehta K
    Cancer Res; 1994 Apr; 54(7):1746-52. PubMed ID: 7511050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Rational Strategy for Reducing On-Target Off-Tumor Effects of CD38-Chimeric Antigen Receptors by Affinity Optimization.
    Drent E; Themeli M; Poels R; de Jong-Korlaar R; Yuan H; de Bruijn J; Martens ACM; Zweegman S; van de Donk NWCJ; Groen RWJ; Lokhorst HM; Mutis T
    Mol Ther; 2017 Aug; 25(8):1946-1958. PubMed ID: 28506593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid induction of CD38 antigen on myeloid leukemia cells by all trans-retinoic acid.
    Drach J; Zhao S; Malavasi F; Mehta K
    Biochem Biophys Res Commun; 1993 Sep; 195(2):545-50. PubMed ID: 7690555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Feasibility of controlling CD38-CAR T cell activity with a Tet-on inducible CAR design.
    Drent E; Poels R; Mulders MJ; van de Donk NWCJ; Themeli M; Lokhorst HM; Mutis T
    PLoS One; 2018; 13(5):e0197349. PubMed ID: 29847570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activated T-cell-mediated immunotherapy with a chimeric receptor against CD38 in B-cell non-Hodgkin lymphoma.
    Mihara K; Yanagihara K; Takigahira M; Imai C; Kitanaka A; Takihara Y; Kimura A
    J Immunother; 2009 Sep; 32(7):737-43. PubMed ID: 19561535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-Multiple Myeloma Activity of Nanobody-Based Anti-CD38 Chimeric Antigen Receptor T Cells.
    An N; Hou YN; Zhang QX; Li T; Zhang QL; Fang C; Chen H; Lee HC; Zhao YJ; Du X
    Mol Pharm; 2018 Oct; 15(10):4577-4588. PubMed ID: 30185037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel Lin-CD34+CD38- integrin α2- bipotential megakaryocyte-erythrocyte progenitor population in the human bone marrow.
    Wong WM; Dolinska M; Sigvardsson M; Ekblom M; Qian H
    Leukemia; 2016 Jun; 30(6):1399-402. PubMed ID: 26500141
    [No Abstract]   [Full Text] [Related]  

  • 11. CD38 is not expressed in pediatric ALK-positive anaplastic large cell lymphoma.
    Au-Yeung RKH; Burkhardt B; Woessmann W; Klapper W
    Pediatr Blood Cancer; 2019 Mar; 66(3):e27541. PubMed ID: 30408331
    [No Abstract]   [Full Text] [Related]  

  • 12. Probing the requirement for CD38 in retinoic acid-induced HL-60 cell differentiation with a small molecule dimerizer and genetic knockout.
    MacDonald RJ; Shrimp JH; Jiang H; Zhang L; Lin H; Yen A
    Sci Rep; 2017 Dec; 7(1):17406. PubMed ID: 29234114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Challenging the adult T-cell leukemia/lymphoma (ATL) stem cell concept based on limiting dilution transplantation assay.
    Bonnefoix T; Callanan M
    Blood; 2010 Mar; 115(10):2117-8; author reply 2118. PubMed ID: 20223932
    [No Abstract]   [Full Text] [Related]  

  • 14. The link between bone microenvironment and immune cells in multiple myeloma: Emerging role of CD38.
    Bolzoni M; Toscani D; Costa F; Vicario E; Aversa F; Giuliani N
    Immunol Lett; 2019 Jan; 205():65-70. PubMed ID: 29702149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 1alpha,25-Dihydroxyvitamin D3 modulates CD38 expression on human lymphocytes.
    Stoeckler JD; Stoeckler HA; Kouttab N; Maizel AL
    J Immunol; 1996 Dec; 157(11):4908-17. PubMed ID: 8943395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigen-induced clustering of surface CD38 and recruitment of intracellular CD38 to the immunologic synapse.
    Muñoz P; Mittelbrunn M; de la Fuente H; Pérez-Martínez M; García-Pérez A; Ariza-Veguillas A; Malavasi F; Zubiaur M; Sánchez-Madrid F; Sancho J
    Blood; 2008 Apr; 111(7):3653-64. PubMed ID: 18212246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Target cell-restricted apoptosis induction of acute leukemic T cells by a recombinant tumor necrosis factor-related apoptosis-inducing ligand fusion protein with specificity for human CD7.
    Bremer E; Samplonius DF; Peipp M; van Genne L; Kroesen BJ; Fey GH; Gramatzki M; de Leij LF; Helfrich W
    Cancer Res; 2005 Apr; 65(8):3380-8. PubMed ID: 15833872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Class 1 HDAC and HDAC6 inhibition inversely regulates CD38 induction in myeloma cells via interferon-α and ATRA.
    Bat-Erdene A; Nakamura S; Oda A; Iwasa M; Teramachi J; Ashtar M; Harada T; Miki H; Tenshin H; Hiasa M; Fujii S; Sogabe K; Oura M; Udaka K; Kagawa K; Yoshida S; Aihara KI; Kurahashi K; Endo I; Abe M
    Br J Haematol; 2019 Jun; 185(5):969-974. PubMed ID: 30474853
    [No Abstract]   [Full Text] [Related]  

  • 19. Upregulation of CD38 expression on multiple myeloma cells by all-trans retinoic acid improves the efficacy of daratumumab.
    Nijhof IS; Groen RW; Lokhorst HM; van Kessel B; Bloem AC; van Velzen J; de Jong-Korlaar R; Yuan H; Noort WA; Klein SK; Martens AC; Doshi P; Sasser K; Mutis T; van de Donk NW
    Leukemia; 2015 Oct; 29(10):2039-49. PubMed ID: 25975191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitamin A and immune function: retinoic acid modulates population dynamics in antigen receptor and CD38-stimulated splenic B cells.
    Chen Q; Ross AC
    Proc Natl Acad Sci U S A; 2005 Oct; 102(40):14142-9. PubMed ID: 16093312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.